Testing for homologous recombination deficiency - does it provide new insights for the use of veliparib?
Gynecol Oncol
.
2022 Feb;164(2):243-244.
doi: 10.1016/j.ygyno.2022.01.018.
Author
Jonathan A Ledermann
1
Affiliation
1
UCL Cancer Institute, University College London, London, UK. Electronic address: j.ledermann@ucl.ac.uk.
PMID:
35086648
DOI:
10.1016/j.ygyno.2022.01.018
No abstract available
Publication types
Editorial
Comment
MeSH terms
Benzimidazoles*
Homologous Recombination
Humans
Poly(ADP-ribose) Polymerase Inhibitors*
Substances
Benzimidazoles
Poly(ADP-ribose) Polymerase Inhibitors
veliparib